• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    115.04 Down 0.97(0.84%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:116.01
    Open:116.33
    Bid:114.90 x 500
    Ask:115.10 x 3800
    1y Target Est:122.00
    Beta:0.87
    Next Earnings Date:27-Jul-15GILD Earnings announcement
    Day's Range:114.91 - 116.49
    52wk Range:84.75 - 123.37
    Volume:8,831,970
    Avg Vol (3m):10,904,000
    Market Cap:169.06B
    P/E (ttm):13.12
    EPS (ttm):8.77
    Div & Yield:1.72 (1.40%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GILD

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 0.84%169.06B
    GSKUp 0.28%102.06B
    PFEDown 0.95%205.48B
    RHHBYUp 0.09%N/A

    Key Statistics

    Forward P/E (1 yr):10.42
    P/S (ttm):6.20
    Ex-Dividend Date:12-Jun-15

    Analysts

    Annual EPS Est (Dec-15) :10.77
    Quarterly EPS Est (Jun-15) :2.64
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):0.81

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback